Jingfeng Liu Selected Research

Cancer Vaccines

3/2021	Cytosolic Delivery of Thiolated Neoantigen Nano-Vaccine Combined with Immune Checkpoint Blockade to Boost Anti-Cancer T Cell Immunity.
1/2017	The Breakthroughs in Cancer Immune Checkpoint Based Therapy: A Review of Development in Immune Checkpoint Study and its Application.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jingfeng Liu Research Topics

Disease

99	Neoplasms (Cancer) 04/2024 - 10/2012
61	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 12/2012
20	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2014
10	Liver Cirrhosis (Hepatic Cirrhosis) 04/2024 - 12/2017
10	Hypoxia (Hypoxemia) 11/2021 - 01/2017
9	Carcinogenesis 01/2022 - 08/2013
8	Fibrosis (Cirrhosis) 03/2024 - 10/2012
8	Liver Neoplasms (Liver Cancer) 12/2018 - 06/2013
7	Sepsis (Septicemia) 10/2023 - 01/2021
6	Infections 06/2022 - 02/2015
6	Thrombosis (Thrombus) 02/2022 - 11/2014
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2023 - 02/2018
5	Cholangiocarcinoma 12/2021 - 01/2018
4	Inflammation (Inflammations) 03/2024 - 03/2018
4	Hepatitis B 10/2023 - 11/2014
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 01/2011
4	Lymphatic Metastasis 08/2021 - 01/2019
3	Liver Failure 01/2024 - 03/2014
3	Hemorrhage 01/2024 - 01/2020
3	Carcinoma (Carcinomatosis) 01/2021 - 06/2013
3	Margins of Excision 09/2020 - 11/2019
2	Acute Kidney Injury (Acute Renal Failure) 05/2024 - 02/2024
2	Rheumatoid Arthritis 03/2024 - 11/2022
2	Experimental Arthritis 03/2024 - 11/2022
2	Hypertension (High Blood Pressure) 01/2023 - 01/2021
2	Rupture 06/2022 - 01/2022
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2017
2	Necrosis 01/2022 - 04/2015
2	Stroke (Strokes) 01/2021 - 01/2021
2	Starvation 01/2021 - 01/2019
2	Hepatitis 01/2021 - 09/2020

Drug/Important Bio-Agent (IBA)

23	Biomarkers (Surrogate Marker)IBA 12/2023 - 08/2013
20	Proteins (Proteins, Gene)FDA Link 12/2023 - 06/2013
9	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2021 - 04/2015
8	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2023 - 01/2020
7	Capsules (Microcapsules)IBA 06/2021 - 10/2012
7	Therapeutic UsesIBA 01/2021 - 09/2017
5	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2017
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2011
5	MicroRNAs (MicroRNA)IBA 01/2021 - 02/2013
4	Cell-Free Nucleic AcidsIBA 10/2023 - 01/2022
4	Circular RNAIBA 01/2023 - 01/2019
4	Anti-Bacterial Agents (Antibiotics)IBA 06/2022 - 08/2020
4	AlbuminsIBA 04/2022 - 01/2020
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
4	Tyrosine Kinase InhibitorsIBA 01/2022 - 02/2018
4	Photosensitizing Agents (Photosensitizers)IBA 11/2021 - 04/2015
4	Fetal Proteins (Fetoprotein)IBA 07/2021 - 10/2012
4	Messenger RNA (mRNA)IBA 12/2017 - 12/2014
3	Dinoprostone (PGE2)FDA Link 04/2024 - 08/2013
3	Small Interfering RNA (siRNA)IBA 01/2023 - 05/2018
3	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2018
3	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 12/2021 - 01/2020
3	phytochlorinIBA 07/2021 - 04/2015
3	Phosphotransferases (Kinase)IBA 07/2020 - 12/2014
3	MetalsIBA 11/2019 - 01/2018
3	AQ4NIBA 01/2019 - 01/2017
3	PolymersIBA 07/2018 - 01/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2024 - 06/2022
2	C-Reactive ProteinIBA 02/2024 - 01/2020
2	acarboxyprothrombin (PIVKA)IBA 12/2023 - 01/2019
2	xanthotoxolIBA 01/2023 - 10/2022
2	Untranslated RNA (Noncoding RNA)IBA 01/2023 - 01/2022
2	VimentinIBA 11/2022 - 05/2018
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 06/2022 - 07/2018
2	LigandsIBA 06/2022 - 01/2019
2	HydrogelsIBA 06/2022 - 01/2019
2	BilirubinIBA 04/2022 - 09/2020
2	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2017
2	IronIBA 01/2022 - 07/2021
2	salicylhydroxamic acid (SHAM)IBA 01/2022 - 10/2021
2	AntigensIBA 01/2022 - 08/2021
2	Oxygen (Dioxygen)IBA 11/2021 - 01/2021
2	TransferasesIBA 10/2021 - 01/2020
2	XuebijingIBA 10/2021 - 08/2021
2	azobenzeneIBA 07/2021 - 07/2018
2	Sorafenib (BAY 43-9006)FDA Link 07/2021 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2021 - 04/2015
2	Cancer VaccinesIBA 03/2021 - 01/2017
2	EnzymesIBA 01/2021 - 10/2019
2	CatalaseIBA 08/2020 - 07/2020
2	Peroxidase (Myeloperoxidase)IBA 08/2020 - 03/2018

Therapy/Procedure

35	Therapeutics 10/2023 - 03/2015
16	Hepatectomy 01/2024 - 01/2014
14	Drug Therapy (Chemotherapy) 06/2022 - 01/2015
13	Photochemotherapy (Photodynamic Therapy) 08/2023 - 04/2015
11	Precision Medicine 11/2021 - 06/2014
9	Lasers (Laser) 01/2022 - 03/2015
8	Photothermal Therapy 01/2021 - 06/2014
5	Transplantation 03/2024 - 05/2016
5	Immunotherapy 03/2022 - 01/2017
4	Blood Transfusion (Blood Transfusions) 01/2024 - 10/2012
4	Liver Transplantation 10/2023 - 10/2015
4	Ligation 03/2023 - 01/2021
4	Punctures 03/2023 - 01/2021
3	Radiotherapy 04/2024 - 01/2017
2	Surgical Portasystemic Shunt (Portosystemic Shunt) 10/2023 - 01/2023
2	Intravenous Injections 01/2023 - 01/2019
2	Injections 08/2021 - 01/2019
2	Aftercare (After-Treatment) 01/2021 - 10/2019